In Depth 30 Jul 2024
Why is the immunology and inflammation market suddenly attracting a wave of investment?
Discover why the immunology and inflammation market has recently been attracting a major wave of investment.
Autoimmune disease
- Latest Posts
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
Best in Biotech 23 Apr 2024
Eight biotechnology companies leading the charge in Poland
Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.
In Depth 27 Mar 2024
Are new treatments for multiple sclerosis on the horizon?
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
In Depth 7 Mar 2024
Can AbbVie’s legacy live beyond its once best-selling drug Humira?
The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.
ADVERTISEMENT
ADVERTISEMENT
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
Podcast 2 Feb 2024
BioSenic showcasing knee osteoarthritis treatment
Explore a groundbreaking approach to knee osteoarthritis treatment with BioSenic’s JTA-004. Listen to our podcast to learn more!
Podcast 8 Dec 2023
Can worms provide treatments for some diseases?
U.S. company Holoclara is looking to tackle diseases through the development of worm-derived therapeutics. Allergic and autoimmune diseases were first described in the early 1900s, which Holoclara said is the same time that gut-resident worms such as the roundworm, Caenorhabditis elegans, were removed from people in industrialized countries. The company, led by CEO Andrea Choe, […]
In Depth 12 Oct 2023
Can immunometabolism-based therapies transform the way cancers and autoimmune diseases are treated?
The immune system protects our bodies from foreign invaders, but sometimes, when it malfunctions, it can result in life-threatening autoimmune disorders. But what if the immune system could be regulated to counter these diseases? Immunometabolism, an emerging field in therapeutics, aims to rein in autoimmunity altogether. According to Neil Weir, chief executive officer (CEO) of […]
Best in Biotech 19 Sep 2023
Five biotech companies taking Los Angeles by storm
Known throughout history for being home to the iconic scene of Hollywood, in recent years Los Angeles has also become a thriving biotech hub, after years of playing second fiddle in the U.S. to the likes of South San Francisco and Boston. In this article, we take a look at five of the best Los […]
Startup Scout 13 Sep 2023
PIM kinase inhibition: a Swiss startup’s unique approach to tackling complex autoimmune disorders
A healthy immune system is supposed to defend the body against disease and infection, but in autoimmune diseases, the immune system malfunctions, and instead attacks the body’s healthy cells, tissues, and organs. Despite recent progress in therapeutic options for autoimmune disorders, a significant unmet need remains, which is why Mysthera Therapeutics is aiming to take […]
ADVERTISEMENT
